UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification Number) |
(Address of principal executive offices, including Zip Code)
Registrant’s telephone number, including
area code: (
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
(Nasdaq Global Select Market) |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
| (a) | On September 8, 2021, Replimune Group, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”) to consider and vote on the two proposals set forth below, each of which is described in greater detail in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on July 22, 2021. |
| (b) | The final voting results on each of the matters submitted to a vote of stockholders at the Annual Meeting are set forth below. |
| (1) | The following director nominees were elected to serve as Class III members of the Company’s board of directors until the Company’s 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified: |
| Nominee | Votes For | Votes Withheld | Broker Non-Votes | |||||||||
| Robert Coffin | 34,793,840 | 7,609,290 | 2,971,499 | |||||||||
| Hyam Levitsky | 26,881,848 | 15,521,282 | 2,971,499 | |||||||||
| Dieter Weinand | 34,943,857 | 7,459,273 | 2,971,499 | |||||||||
| (2) | The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2022 was ratified. |
| Votes For | Votes Against | Votes Abstaining | ||||||||
| 45,373,696 | 232 | 701 | ||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| REPLIMUNE GROUP, INC. | ||
| Date: September 9, 2021 | By: | /s/ Jean Franchi |
| Jean Franchi | ||
| Chief Financial Officer | ||